Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
LifeMD, Inc. (CVLB)
|
Add to portfolio |
|
|
|
| Price: |
$4.05
| | Metrics |
| OS: |
36.0
|
M
| |
|
|
| Market cap: |
$146
|
M
| |
|
|
|
Net debt:
|
$2.37
|
M
| |
|
|
|
EV:
|
$148
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($12.7)
|
M
| |
|
|
|
EBIT
|
($14.0)
|
M
| |
|
|
| EPS |
($1.05)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 119.0 | 92.9 | 37.3 | 12.5 | 8.3 | 5.1 | 5.2 | 1.2 |
| Revenue growth | 28.2% | 149.0% | 199.1% | 49.8% | 64.7% | -3.5% | 329.8% | 70.7% |
| Cost of goods sold | 18.7 | 18.0 | 8.9 | 2.5 | 2.0 | 1.5 | 1.9 | 0.8 |
| Gross profit | 100.4 | 74.9 | 28.4 | 9.9 | 6.3 | 3.6 | 3.3 | 0.4 |
| Gross margin | 84.3% | 80.6% | 76.2% | 79.7% | 76.0% | 70.6% | 62.9% | 36.0% |
| Sales and marketing | 78.4 | 82.5 | 39.1 | 8.9 | 5.1 | 1.7 | 1.7 | 0.2 |
| Research and development | | | | | | | | 0.0 |
| General and administrative | 47.0 | 39.5 | 45.0 | 2.4 | 2.3 | 1.3 | 1.5 | 0.4 |
| EBITA | -28.6 | -54.0 | -57.5 | -2.6 | -1.9 | -1.1 | -1.2 | -0.3 |
| EBITA margin | -24.0% | -58.1% | -154.1% | -20.5% | -22.3% | -21.1% | -22.4% | -21.5% |
| Amortization of intangibles | 0.9 | 0.3 | 0.3 | 0.3 | 0.2 | | | |
| EBIT | -29.5 | -54.3 | -57.8 | -2.9 | -2.1 | -1.1 | -1.2 | -0.3 |
| EBIT margin | -24.8% | -58.5% | -155.0% | -23.2% | -24.7% | -21.1% | -22.4% | -21.5% |
| Pre-tax income | -44.7 | -61.3 | -60.4 | -3.7 | -2.4 | -1.2 | -1.2 | -0.2 |
| Income taxes | 0.4 | 0.0 | 0.1 | -0.1 | -0.1 | 0.0 | -0.1 | 0.0 |
| Tax rate | | | | 3.4% | 5.2% | 1.0% | 9.5% | 7.7% |
| Earnings from continuing ops | -48.6 | -61.8 | -63.4 | -3.1 | -2.2 | -1.2 | -1.1 | -0.1 |
| Earnings from discontinued ops | | | | | 0.9 | | | |
| Net income | -48.6 | -61.8 | -63.4 | -3.1 | -1.2 | -1.2 | -1.1 | -0.1 |
| Net margin | -40.9% | -66.5% | -169.9% | -25.2% | -14.9% | -23.9% | -21.1% | -5.1% |
| |
| Diluted EPS | ($1.57) | ($2.29) | ($4.44) | ($0.32) | ($0.05) | ($0.03) | ($0.03) | $0.00 |
| Shares outstanding (diluted) | 31.0 | 27.0 | 14.3 | 9.9 | 44.2 | 41.7 | 33.5 | 30.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|